Abbreviations : b-gal117S4H, a truncated E. coli b-galactosidase derivative; GLP-1, glucagon-like peptide-1 (7-36) amide; GLP-1 [G], the C-terminally glycine extended precursor peptide of human 
Though OmpT has been reported to mainly cleave the peptide bond between consecutive basic amino acids, we identiˆed more precise substrate speciˆcity by using a series of modiˆed substrates, termed PRX fusion proteins, consisting of 184 residues. The cleavage site of the substrate PRR was Arg 140 -Arg 141 and the modiˆed substrates PRX substituted all 19 natural amino acids at the P1? site instead of Arg 141 . OmpT under denaturing conditions (in the presence of 4 M urea) cleaved not only between two consecutive basic amino acids but also at the carboxyl side of Arg 140 except for the Arg 140 -Asp 141 , -Glu 141 , and -Pro 141 pairs. In addition to Arg 140 at the P1 site, similar results were obtained when Lys 140 was substituted into the P1 site. In the absence of urea, an aspartic acid residue at the P1? site was unfavorable for OmpT cleavage of synthetic decapeptides, the enzyme showed a preference for a dibasic site.
Key words: Escherichia coli; outer membrane protein OmpT endoprotease (EC 3.4.21.87); substrate speciˆcity; denaturing conditions Escherichia coli OmpT is an outer membranebound endoprotease consisting of 297 amino acid residues. 1, 2) It belongs to the serine peptidase family S18 3) and the deduced amino acid sequence has high similarity to those of the Yersinia pestis plasminogen activator, 4) Salmonella typhimurium E protein, 5) E. coli OmpP, 6) and Shigella ‰exneri SopA proteins.
7)
The physiological function of OmpT has been suggested to be involved in E. coli pathogenicity 8) and the inactivation of antimicrobial peptides. 9) The hydrolysis of T7 RNA polymerase, 10) human interferon gamma, 11) and cyclin A 12) by this enzyme has been reported. In some cases, undesired degradation of recombinant proteins expressed by E. coli also occurs. OmpT has the ability to process recombinant fusion proteins such as cholesterol esterase W lipase, 13) cholera toxin B subunit, 14) and recombinant Staphylococcus aureus V8 protease derivative.
15) The narrow substrate speciˆcity contributes to OmpT being a useful processing enzyme for recombinant fusion proteins.
Although OmpT primarily cleaves the peptide bond between consecutive basic residues, 2) not all dibasic sites were cleaved.
11) Moreover, OmpT is known to cleave monobasic amino acid sites such as Arg-Met, 16) Arg-Ala, 17) and Arg-Val.
18)
Recently Dekker et al. have investigated the substrate speciˆcity for the P2, P1, P1?, and P2? positions of OmpT using synthetic peptides called SPOT peptide libraries. 19) Here, we identiˆed the more precise substrate speciˆcity by using a series of modiˆed substrates, termed PRX fusion proteins, consisting of 184 residues, but not synthetic peptides, under denaturing conditions. As regards the speciˆcity for the P1? position, ourˆnding corresponded with their results in the point of the less exclusive preference although there were some diŠerences in the cleavage e‹ciencies.
OmpT is associated in inclusion bodies and active in the presence of high concentrations of urea. 20) Therefore, as soon as inclusion bodies containing a fusion protein are dissolved in denaturation solution with urea, OmpT can cleave the fusion protein to release the target peptide without external addition of any protease. 15) Thus, OmpT has a suitable property for processing fusion proteins when they are in inclusion bodies. In this paper, long and free peptides were used as substrates under denaturing conditions. Hence, our results could be applied to site-speciˆc cleavage of protein and peptide when we consider the application of OmpT as a processing protease.
Materials and methods
Materials. Plasmid pG117S4HompPRR (Fig. 1A ) was used to construct the mutated fusion protein variants and as a template for PCR ampliˆcation. It is a pBR322-derived high-copy plasmid that encodes the PRR fusion protein the expression of which is under the control of the E. coli lac promoter. This fusion protein is designed to produce the recombinant C-terminally glycine extended precursor peptide of human GLP-1 (7- 36) (GLP-1 [G] ). E. coli JM109 was used as the host for plasmid construction. E. coli W3110 M25, which is an OmpT proteasedeˆcient mutant derived from E. coli W3110, 21) was used for expression of the fusion proteins. DNA restriction enzymes were purchased from New England Biolabs, Beverly, MA, USA. Dynorphin A 1-13 was purchased from the Peptide Institute, Osaka, Japan. Benzamidine Sepharose 6B was obtained from Amersham Pharmacia Biotech, Uppsala, Sweden. Both YMC Protein RP and YMC A-302 HPLC columns were obtained from YMC, Kyoto, Japan. Synthetic peptides RR (Glu-Leu-Arg-Leu-Tyr-Arg-Arg-HisHis-Gly) and RD (Glu-Leu-Arg-Leu-Tyr-Arg-AspHis-His-Gly) were synthesized with a Model 433A peptide synthesizer (PE Biosystems, Foster City, CA, USA). Synthetic peptide KR (Glu-Leu-Arg-Leu-TyrLys-Arg-His-His-Gly) and RN (Glu-Leu-Arg-LeuTyr-Arg-Asn-His-His-Gly) were purchased from Sawady Technology, Tokyo, Japan. Protein concentrations were measured by the BCA assay (Pierce, Rockford, IL, USA).
Construction of plasmids. The fusion protein (PRR, 184 residues) consists of a truncated E. coli bgalactosidase (b-gal117S4H) as a protective peptide fused to the precursor of human glucagon-like peptide-1 (GLP-1 [G]) via a linker peptide. It has an OmpT cleavage site at Arg 140 -Arg 141 deˆned as the P1 and P1? sites in the linker peptide, respectively. The codon corresponding to the P1? site on the plasmid pG117S4HompPRR (Fig. 1A) was acted on by sitedirected mutagenesis to generate 19 diŠerent fusion protein genes of type PRX (where X denotes a substituted amino acid-residue at the P1? site), as substrates for OmpT as shown in Fig. 1B . The expression plasmids pG117S4HompPRX were constructed as follows. The plasmid pG117S4HompPRR was used as a template for PCR ampliˆcation. The upper primer 5?-ACCCC AGGCT TTACA CTTTA-3? is located in the E. coli lac promoter-operator region. The lower primer 5?-CCGGA TCCGT GATGN NNGCG ATACA GGCG-3? is complementary to the fusion protein linker sequence containing the changes at the codon of the P1? site (where NNN is complementary to the desired codon for the amino acid to be tested in the P1? site). The PCR product was digested with PvuI and BamHI and puriˆed from the agarose gel. It was inserted into the same site of pG117S4HompPRR to create the series of mutations at the P1? site. For the construction of the fusion protein genes that have Lys instead of Arg at the P1 site, the expression plasmids pG117S4HompPKA, pG117S4HompPKS, pG117S4HompPKK, pG117-S4HompPKR, pG117S4HompPKD and pG117-S4HompPKE were constructed. PCR ampliˆcation was done by using the upper primer 5?-ACCCC AGGCT TTACA CTTTA-3? and the lower primer 5?-CCGG ATCCG TGATG NNNTT TATAC AGGCG-3? (NNN designates AGC for PKA, AGA for PKS, TTT for PKK, ACG for PKR, GTC for PRD, or TTC for PKE) complementary to the fusion protein linker. PCR products were digested with PvuI and BamHI. The DNA fragment was inserted into the same site of pG117S4HompPRR to generate these fusion protein genes. The nucleotide sequences of each mutated fusion protein gene were conˆrmed using an A. L. F. Sequencer (Amersham Pharmacia Biotech.).
Preparation of fusion proteins. OmpT proteasedeˆcient E. coli W3110 M25 cells harboring each fusion protein expression plasmid were grown in 400 mL of Luria Bertani medium containing 10 mg W mL of tetracycline at 379 C overnight. The cells were harvested by centrifugation and disrupted by sonication. The expressed fusion proteins were found as insoluble inclusion bodies. This insoluble fraction was harvested by centrifugation and then washed with 50 mM Tris-HCl (pH 7.5) containing 5 mM EDTA and 1z Triton X-100. The remaining insoluble fraction was further washed with deionized water and suspended in deionized water to an OD 660 for the suspension equal to 100, which was used as substrate. It was stored at "209 C until use.
Preparation of OmpT. OmpT protease was expressed in E. coli W3110 transformed with the plasmid pOmpTTcE that was constructed by replacing the coding region of the fusion protein in pG117S4HompPRR with the ompT gene cloned by Sugimura. 21) The OmpT protease expressing E. coli cells was grown in a 3-L fermentor with 2 L of the medium of Mori et al. 22) at 379 C for 12 hours. The cells were harvested by centrifugation. After washing with 50 mM Tris-HCl (pH 7.5) twice, the cells were homogenized using a Manton-Gaullin homogenizer. The membrane extract was prepared from the whole membrane fraction by the method of Sugimura and Nishihara, 2) and the extract (120 mL) was put on a benzamidine Sepharose 6B column (8 mL) equilibrated with buŠer A (50 mM Tris-HCl [pH 7.5] containing 0.1z Triton-X100). The column was washed with 10 column volumes of buŠer A, and the adsorbed proteins were eluted with buŠer A containing 0.3 M NaCl. The active fractions were analyzed by SDS-PAGE. Only the fraction showing a single band was used as a puriˆed OmpT protease.
OmpT protease activity assay. For measurement of OmpT protease activity, the substrate dynorphin A was used according to the method of Sugimura and Nishihara.
2) A 20-mL reaction mixture was analyzed by reverse phase HPLC using a YMC Protein RP column. Elution was done with a linear gradient of 10 to 15z acetonitrile in a 0.1z tri‰uoroacetic acid solution at a ‰ow rate of 1 mL W min, the eOEuent being monitored by absorbance at 220 nm. One unit of OmpT protease activity was deˆned as that cleaving 1 mmol of dynorphin A per min at 259 C.
Cleavage of fusion proteins. A 10-mL portion of the substrate inclusion bodies suspension (OD660＝ 100) of each fusion protein was solubilized in 20 mL of 10 M urea. Sodium phosphate (1 M, pH 7.0) and EDTA (50 mM) were added to giveˆnal concentrations of 50 mM and 2 mM, respectively. The reaction was started by the addition of 5 mL of 4 units W mL OmpT in a total volume of 50 mL. The reaction mixtures were incubated for 30 min at 259 C and analyzed by SDS-PAGE. The band intensities on the gel were measured by scanning with a computing densitometer Model 300A (Molecular Dynamics, Sunnyvale, CA, USA) after Coomassie Brilliant Blue R250 staining.
Identiˆcation of the cleavage sites. The OmpT reaction product from each fusion protein was puried from the reaction mixture described above. An equal volume of 12z acetic acid and 4 M urea was added to the reaction mixture. After centrifugation, the supernatant was put on a YMC Protein RP column. Elution was done with a linear gradient of 21.5 to 32z acetonitrile in a 0.1z tri‰uoroacetic acid solution at a ‰ow rate of 1 mL W min. The peptide fragment containing GLP-1 [G] was pooled and amino acid sequence was analyzed with a Model 477A protein sequencer (PE Biosystems, Foster City, CA, USA).
Calculation of kinetic constants. Kinetic data were obtained by incubating various concentrations of the synthetic decapeptides, RR, KR, and RN with 0.11 nM, 0.23 nM, and 90 nM of constant OmpT concentrations, respectively. Peptide concentrations were chosen where possible to surround the Km. The reactions were done as described in``OmpT protease activity assay.'' except for substituting these peptides instead of dynorphin A as the substrate. A reaction mixture (20 mL) was analyzed by reverse phase HPLC with a YMC A-302 column. Elution was done with a linear gradient of 10 to 40z acetonitrile in a 0.1z tri‰uoroacetic acid solution at a ‰ow rate of 1 mL W min, the eOEuent being monitored by absorbance at 214 nm. The amount of the cleaved peptide Glu-Leu-Arg-Leu-Tyr-Arg (from RR and RN), or Glu-Leu-Arg-Leu-Tyr-Lys (from KR) was estimated from the peak area of the chromatogram. Data werê tted to the Michaelis-Menten rate equation.
Results and discussion
EŠects of the P1? site on OmpT cleavage OmpT was originally described as a protease cleaving the bonds between two consecutive basic amino acids (Arg-Arg, Arg-Lys, Lys-Lys, and Lys-Arg); 2) since then monobasic sites such as Arg-Met, 16) ArgAla, 17) and Arg-Val 18) have been reported as targets. In order to investigate the eŠects on OmpT cleavage of the P1? site, 19 other amino acids were used to replace the residue at the P1? position of the cleavage site in the fusion proteins PRX (Fig. 1B) . All of the PRX fusion proteins were prepared in the OmpT protease-deˆcient E. coli W3110 M25 strain. 21) OmpT cleavage of the twenty fusion proteins was done in the presence of 4 M urea to solubilize the fusion proteins. It has been observed that OmpT proteolysis is active even under extreme denaturing conditions (8 M urea). 20) As shown in Fig. 2 , all of the fusion proteins were cleaved except for PRD (lane D) and PRE (lane E). These results indicate that acidic amino acids are disallowed at the P1? site for cleavage. The cleavage e‹ciency of the fusion protein was aŠected by the amino acid species at the P1? site. The cleavage of PRR and PRK was more e‹cient than that of the other fusion proteins. The results of N-terminal amino acid sequences of the 4.9-kDa cleavage products showed that all of the cleaved fusion proteins, except for PRP, were cleaved at Arg 140 -X 141 , but PRN, PRY, PRG, PRH and PRW were also moderately cleaved at Arg 137 -Leu 138 as well ( 19) As regards the speciˆcity for the P1? position, ourˆnding corresponded with their results in the point of the less exclusive preference. Furthermore, it was conˆrmed that basic amino acids were preferred and acidic amino acids were not allowed at the P1? position. However, there were some diŠerences in the cleavage e‹ciencies. In the SPOT peptide analysis, Arg-Cys, Arg-Tyr, and Arg-Trp were reported as poor substrates (0-5z cleavage). In contrast, we observed higher cleavages for these sequences (36z, 22z, and 6.2z, respectively). In the case of Arg-Pro sequence, 10z cleavage was detect- ed in the SPOT peptide analysis. However, we could not detect cleavage for Arg-Pro in our fusion protein. These might be due to the diŠerence of the substrates (the number of amino acid residues, the peptide sequences, immobilized or free peptides) or the reaction conditions (pH, incubation time, with or without urea). Detailed analysis will be needed to clarify the diŠerences.
In the fusion protein PRR, there is another potential OmpT cleavage site at Arg 14 -Lys 15 . The cleavage at this site could not be detected even under denaturing conditions. This might be due to the existence of acidic residues (Asp and Glu) at P2? and P4? position of Arg 14 -Lys 15 sequence. Dekker et al. showed that peptides containing an acidic residue at P2 or P2? were not substrates for OmpT and suggested that long-range electrostatic interactions are important for the formation of the enzyme-substrate complex. 19) In this context, the use of long and free peptides as substrates is signiˆcant. When we consider the application of OmpT as a processing protease under denaturing conditions, our results could be applied to site-speciˆc cleavage of proteins and peptides.
EŠects of a Lys residue at the P1 site on cleavage Though Arg at the P1 site seemed essential for cleavage, the Arg 140 at P1 was nevertheless replaced by Lys. Arg 141 at the P1? site was also replaced by the six amino acids shown in Fig. 3A . After the PKXs were incubated with or without OmpT, the reaction mixtures were analyzed by SDS-PAGE (Fig. 3B) . PKR, PKK, PKA, and PKS were cleaved, but PKD and PKE were not cleaved by OmpT. These results approximately corresponded with those of the fusion protein PRXs (Arg at the P1 site). Moreover, the (Table 2 ). These results show that OmpT cleaves at the same site after replacement with Arg, Lys, Ser, or Ala at the P1? site even when Lys is present at the P1 site. A basic amino acid at the P1 site is likely to be essential for cleavage because the fusion protein, which has Ala 140 (P1)-Arg 141 (P1?), was not cleaved (data not shown).
Kinetics measurements with synthetic peptides
Analysis with the fusion proteins as substrates indicated that OmpT cleaved most bonds of the type Arg-X except where X was Asp, Glu, or Pro. The enzyme also cleaved at Lys-Lys, Lys-Arg, Lys-Ser, and Lys-Ala. In addition, dibasic sites were cleaved more e‹ciently than monobasic sites in the presence of 4 M urea. In order to conˆrm these observations in the absence of urea and to measure OmpT speciˆcity for the P1 and P1? sites, kinetic constants were measured using the synthetic decapeptides, RR, KR, RN, and RD in the absence of urea. The sequences of these decapeptides are indicated in Table 3 . The diŠerences among decapeptides RR, RN, and RD are that the P1? site is Arg, Asn, or Asp, respectively. The Km, kcat, and catalytic e‹ciencies (kcat W Km) of each substrate are shown in Table 3 . The Km on RR was lower than that on RN, and the kcat on RR was higher. The catalytic e‹ciency on RR was much higher than that on RN (1600-fold). RD was not detectably hydrolyzed. Therefore, OmpT prefers the basic amino acid Arg over the neutral amino acid Asn and refuses the acidic amino acid Asp at the P1? site. It seems that OmpT recognizes the charge of the amino acid rather than the structure of the P1? residue. Furthermore, these results suggest that OmpT can cleave at monobasic sites except for Arg-Asp, Arg-Glu, and ArgPro even under native conditions. These results are comparable with those for fusion protein cleavage under denaturing conditions. In a comparison be- In these experiments, we studied the P1? site speciˆcity of OmpT using long and free peptide substrates. We are continuing to study the in‰uence of the adjacent amino acid residues on the cleavage by OmpT.
